Xinguang Pharmaceutical: Announcement on the expiration of the company’s shareholding reduction plan for shareholders holding more than 5% of the company’s shares
Securities code: 300519 Securities abbreviation: Xinguang Pharmaceutical Announcement number: 2026-002
Zhejiang Xinguang Pharmaceutical Co., Ltd.
Announcement on the expiration of the company’s shareholding reduction plan for shareholders holding more than 5% of the company’s shares
Shengzhou Hefeng Investment Co., Ltd., a shareholder holding more than 5% of the shares, guarantees that the information provided to the company is true, accurate and complete, and contains no false records, misleading statements or major omissions.
The company and all members of the board of directors guarantee that the content of the announcement is consistent with the information provided by the information disclosure obligor.
Zhejiang Xinguang Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") will be On March 7, the "Pre-Disclosure Announcement on Shareholding Reduction by Shareholders Holding More than 5% of the Shares" (Announcement No.: 2025-033) was disclosed. The company's shareholder holding more than 5% of the shares, Shengzhou Hefeng Investment Co., Ltd. (hereinafter referred to as "Hefeng Investment") plans to reduce its holdings of the company's shares by a total of no more than 4,800,000 through centralized bidding transactions or block transactions within 3 months after 15 trading days from the date of announcement disclosure. shares (i.e. no more than 3% of the company’s total share capital).
Hefeng Investment reduced its holdings of the company's shares by a total of 10,700,100 shares from January 4, 2022 to February 5, 2026. The proportion of its shares held in the company's total share capital dropped from 21.6875% to 14.9999%, and the change in equity touched an integral multiple of 5%. The company disclosed "About Shareholdings" on cninfo.com on February 6, 2026 Indicative announcement on the change of the shareholding ratio of more than 5% shareholders touching an integer multiple of 5% and the disclosure of a simplified equity change report (announcement number: 2026-001).
Recently, the company received the "Notification Letter Regarding the Expiration of the Share Reduction Plan" submitted by the shareholder Hefeng Investment, indicating that the share reduction plan has expired. During this shareholding reduction plan, Hefeng Investment reduced its holdings of 971,100 shares of the company through centralized bidding transactions on the Shenzhen Stock Exchange (accounting for 0.6069% of the company's total share capital), and reduced its holdings of 210,000 shares of the company's shares (accounting for 0.1313% of the company's total share capital) through block transactions.
The implementation status of the shareholding reduction of Hefeng Investment is now announced as follows:
1. Shareholding reduction by shareholders
- Specific implementation of the shareholding reduction plan
Number of shares reduced Shareholding reduction ratio Name of shareholder Shareholding reduction method Period of shareholding reduction Average price of shareholding reduction
(Share) (%) 2025.12.03-
Centralized bidding transaction 16.21 971,100 0.6069 Shengzhou City Hefeng 2026.02.05
Block Transaction 2026.01.05 11.92 210,000 0.1313 Investment shares
Other methods —— —— —— —— Co., Ltd.
Total —— 15.45 1,181,100 0.7382
The reduction of shares held by Hefeng Investment comes from the shares held before the initial public offering and listing of the shares and the shares obtained by converting capital reserve funds into equity after the shares were listed.
- Shareholding status of shareholders before and after this reduction
Shares held before this shareholding reduction plan Name of shareholders holding shares after this shareholding reduction plan Nature of shares
Ratio to total equity Ratio to total equity Number of shares (shares) Number of shares (shares)
Example(%) Example(%)
Total shares held 25,181,000 15.7381 23,999,900 14.9999Shengzhou City Hefeng
Investment shares include: shares without sales restrictions 25,181,000 15.7381 23,999,900 14.9999 Co., Ltd.
Shares subject to sales restrictions —— —— —— ——
2. Other related instructions
During the implementation of this shareholding reduction plan, Hefeng Investment actually reduced its holdings by 1,181,100 shares through centralized bidding and block transactions. The quantity and price of the reduction were within the scope of the previously disclosed reduction plan. The actual reduction was consistent with the previously disclosed commitments and share reduction plan.
The implementation of the shareholding reduction plan of Hefeng Investment complies with the provisions of the Company Law, the Securities Law, the Interim Measures for the Management of Share Reductions by Shareholders of Listed Companies, the Shenzhen Stock Exchange GEM Stock Listing Rules, the Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 2 - Standardized Operations of GEM Listed Companies, the Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 18 - Reduction of Shareholdings by Shareholders, Directors and Senior Management and other laws, regulations, departmental regulations and normative documents, and there is no violation of relevant commitments of shareholders.
As of the date of this announcement, shareholder Hefeng Investment holds 14.9999% of the company’s shares and is still a shareholder holding more than 5% of the company’s shares;
Hefeng Investment, the shareholder that reduced its shareholding this time, is not the company's controlling shareholder and actual controller. The implementation of the shareholding reduction will not affect the company's governance structure and ongoing operations, nor will it cause a change in the company's control.
3. Documents for reference
"Notification Letter Regarding the Expiration of the Share Reduction Plan" issued by Hefeng Investment;
Other documents required by Shenzhen Stock Exchange.
Announcement is hereby made.
Board of Directors of Zhejiang Xinguang Pharmaceutical Co., Ltd.
March 2, 2026